Envista (NVST)
(Real Time Quote from BATS)
$19.79 USD
+0.11 (0.56%)
Updated May 1, 2024 10:20 AM ET
4-Sell of 5 4
B Value D Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NVST 19.79 +0.11(0.56%)
Will NVST be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for NVST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVST
Envista (NVST) Faces Macroeconomic Challenges, FX Headwind
Envista (NVST) Down 5.8% Since Last Earnings Report: Can It Rebound?
NVST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Envista (NVST) Q4 Earnings Miss Estimates, Margins Down
Envista (NVST) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Medical Products Stocks' Earnings Due on Feb 7: STE, PAHC & NVST
Other News for NVST
Envista Q1 2024 Earnings Preview
Envista just downgraded at Morgan Stanley, here's why
Envista Holdings: Navigating Leadership Changes and Long-Term Turnaround Challenges
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), Nyxoah (NYXH) and Zoetis (ZTS)
Envista Announces CEO Appointment